Marcos Steinberg
5Patents
2h-index
25Co-inventors
47Inventor score
Filing activity: Jun 3, 2005 → May 11, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8349320B2 | Compositions and methods for modulating responses mediated or associated with BTLA activity | Chemistry; Metallurgy | 5 | Active |
| US9700606B2 | HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use | Physics | 4 | Active |
| US8394777B2 | Treating immunodeficiencies by intrathymic injection of nucleotide sequences | Chemistry; Metallurgy | 0 | Active |
| US10220081B2 | Methods of modulating HVEM, BTLA and CD160 cis complex response or signaling activity with soluble light polypeptide sequences | Physics | 0 | Active |
| US11040954B1 | CXCR3 receptor agonists | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.